Evidence map›Paper›PMID 21411513›Full record

ArticleDiabetes2011

Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats.

Owen Chan, Sachin Paranjape, Daniel Czyzyk, Adam Horblitt, Wanling Zhu, Yuyan Ding, Xiaoning Fan, Margretta Seashore, Robert Sherwin

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Function of the GABAergic System in Diabetic Encephalopathy.Cellular and molecular neurobiology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Owen ChanSection of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. owen.chan@yale.edu
Sachin Paranjape
Daniel Czyzyk
Adam Horblitt
Wanling Zhu
Yuyan Ding
Xiaoning Fan
Margretta Seashore
Robert Sherwin
Yale University · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
GLUCOREGULATORY HORMONE INTERACTIONS IN DIABETESR37DK020495 · NIDDK · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 1995 to 2012
$7.3M
GLUCOREGULATORY HORMONE INTERACTIONS IN DIABETESR01DK020495 · NIDDK · YALE UNIVERSITY · PI ROTHMAN, DOUGLAS LYLE · 1986 to 2022
$6.6M
NIDDK NIH HHS DK-20495NIDDK NIH HHS DK-45735NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK020495NIDDK NIH HHS R37 DK020495
6 · The paper itself

Abstract

objectiveImpaired glucose counterregulation during hypoglycemia is well documented in patients with type 1 diabetes; however, the molecular mechanisms underlying this defect remain uncertain. We reported that the inhibitory neurotransmitter γ-aminobutyric acid (GABA), in a crucial glucose-sensing region within the brain, the ventromedial hypothalamus (VMH), plays an important role in modulating the magnitude of the glucagon and epinephrine responses to hypoglycemia and investigated whether VMH GABAergic tone is altered in diabetes and therefore might contribute to defective counterregulatory responses. RESEARCH DESIGN AND

methodsWe used immunoblots to measure GAD(65) protein (a rate-limiting enzyme in GABA synthesis) and microdialysis to measure extracellular GABA levels in the VMH of two diabetic rat models, the diabetic BB rat and the streptozotocin (STZ)-induced diabetic rat, and compared them with nondiabetic controls.

resultsBoth diabetic rat models exhibited an ~50% increase in GAD(65) protein as well as a twofold increase in VMH GABA levels compared with controls under baseline conditions. Moreover, during hypoglycemia, VMH GABA levels did not change in the diabetic animals, whereas they significantly declined in nondiabetic animals. As expected, glucagon responses were absent and epinephrine responses were attenuated in diabetic rats compared with their nondiabetic control counterparts. The defective counterregulatory response in STZ-diabetic animals was restored to normal with either local blockade of GABA(A) receptors or knockdown of GAD(65) in the VMH.

conclusionsThese data suggest that increased VMH GABAergic inhibition is an important contributor to the absent glucagon response to hypoglycemia and the development of counterregulatory failure in type 1 diabetes.

Indexed as

AnimalsDiabetes Mellitus, Experimentalgamma-Aminobutyric AcidGlucose Clamp TechniqueGlutamate DecarboxylaseHypoglycemiaImmunoblottingMaleMicrodialysisRatsRats, Sprague-DawleyVentromedial Hypothalamic Nucleusgamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 2

Identifiers

PMID21411513
PMCPMC3292334
OpenAlexW1996030698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.